A Study To Investigate Safety, Tolerability, And Pharmacokinetics Of PF-00868554 In Japanese Healthy Adult Volunteers

Stopped early · Phase 1 · Has a placebo group

Conditions studied: Healthy Volunteers

In brief

Investigation of safety, tolerability, and pharmacokinetics of PF-00868554 following multiple oral administrations of PF-00868554 in Japanese healthy adult volunteers.

Key facts

Study ID

NCT00875628

Run by

Pfizer

People needed

24

Starts

2009-04-01

Expected to finish

2009-04-01

Last updated by the study team

2009-10-22

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy male and female Japanese subjects between the ages of 18 and 55 years.
• Body Mass Index (BMI) of 17.5 to 30.5 kg/m2; and a total body weight >50 kg (110 lbs).

You may not qualify if…

• Male subjects with a history of subfertility/infertility and other conditions that in the opinion of the investigator may affect fertility.
• Exposure within the previous three months to a drug known to have a negative effect on skeletal muscle or reproductive organs.
• Pregnant or nursing females; females of childbearing potential.

Where it is running

• Pfizer Investigational Site — Glendale, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.